Clinical Trial: Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
COVID-19
SARS-CoV-2 Infection
Study Type: Interventional
Official Title: A Randomized, Observer-Blinded, Phase 3 Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
Brief Summary:
This is a randomized, Phase 3 study comparing the immunogenicity and safety of 3 different lots of Novavax vaccine with Matrix-M™ adjuvant (NVX-CoV2373).The study will enroll approximately 900 previously vaccinated adults 18 to 49 years of age, inclusive.
Read more